The Miraculous NASA Breakthrough That Could Save Millions of Lives (UPDATED)

On our home planet, the NASA Biocapsule's primary target is diabetes—specifically, patients who need insulin. Says Dr. Loftus:

The capsule would contain pancreatic islet cells (from animals) or would contain engineered cells designed to behave like pancreatic islet cells, with both glucose-sensing and insulin secretion function. Patients with low-insulin requirement might benefit from implantation of a single capsule (containing perhaps a million to 10 million cells); patients with higher insulin requirement might require implantation of more than one capsule.

In other words, diabetes patients might never need to give themselves another shot. They wouldn't have to worry about remembering to bring medicine everywhere, and they might even be free of having to constantly monitor their blood-sugar levels. Plus, many diabetes patients lapse into comas or die during sleep because that's eight hours every day when they can't monitor their levels. The NASA Biocapsules would work automatically, regardless of whether you're awake or not. As of 2010 there were an estimated 285 million people living with diabetes, so saying that this invention could potentially save millions of lives is not an exaggeration.